Skip to content

Artificial Intelligence Versus Expert Endoscopists for Diagnosis of Gastric Cancer

A Single-center, Retrospective, Open Label, Randomized Controlled Trial of Artificial Intelligence Versus Expert Endoscopists for Diagnosis of Gastric Cancer in Patients Who Underwent Upper Gastrointestinal Endoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04040374
Enrollment
500
Registered
2019-07-31
Start date
2019-07-01
Completion date
2019-11-16
Last updated
2019-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

artificial intelligence, gastric cancer

Brief summary

Title: A single-center, retrospective randomized controlled trial of artificial intelligence (AI) versus expert endoscopists for diagnosis of gastric cancer in patients who underwent upper gastrointestinal endoscopy. Précis: this single-center, retrospective randomized controlled trial will include 500 outpatients who underwent upper gastrointestinal endoscopy for gastric cancer screening and will compare the diagnostic detection rate for gastric cancer of AI and expert endoscopists. Objectives Primary Objective: to evaluate the diagnostic detection rate for gastric cancer of AI and expert endoscopists. Secondary Objectives: to determine whether AI is not inferior to expert endoscopists in terms of the number of images analyzed for diagnosis of gastric cancer and intersection over union (IOU), and the detection rate of diagnosis of early and advanced gastric cancer. Endpoints Primary Endpoint: diagnosis of gastric cancer. Secondary Endpoints: image based diagnosis of gastric cancer and IOU. Population: in total, 500 males and females aged ≥ 20 years who underwent upper gastrointestinal endoscopy for screening of gastric cancer at a single hospital in Japan. Describe the Intervention: AI-based diagnosis of gastric cancer based on upper gastrointestinal endoscopy images. Study Duration: 3 months.

Detailed description

Prior to Study: Total 500: Screen potential subjects by inclusion and exclusion criteria; obtain endoscopy images. Randomization was performed. Intervention: AI diagnosis was performed for 250 patients using upper gastrointestinal endoscopy images, and Expert endoscopists diagnosis was performed for 250 patients by same methods. Primary analysis: Perform primary analysis of primary and secondary endpoints for 250 patients in each group Cross over diagnosis between AI and expert endoscopists was performed. Perform secondary analysis of agreement of gastric cancer diagnosis per images and IOU between AI and expert endoscopists for 500 patients.

Interventions

DIAGNOSTIC_TESTAI-based diagnosis

AI-based diagnosis will be performed based on analysis of endoscopic images (Olympus Optical, Tokyo, Japan). The investigators will use the Single Shot MultiBox Detector (SSD), a deep neural network architecture (https://arxiv.org/abs/1512.02325), and an optimal diagnostic cutoff from a prior report2. The AI system reviewed endoscopy images and reported those in which gastric cancer was detected, together with the coordinates (X, Y) of the lesions.

DIAGNOSTIC_TESTThe expert endoscopists-based diagnosis

The expert endoscopists are two physicians with experience of more than 20,000 endoscopies. The expert endoscopists will review the endoscopy images of each patient for 5 min. They will then report endoscopy images in which gastric cancer was detected and manually annotate the lesions in those images.

Sponsors

Tokyo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Males or females aged ≥ 20 years who underwent upper gastrointestinal endoscopy at Tokyo University Hospital during 2018. 2. Informed optout consent, obtained from each patient before completion of the study.

Exclusion criteria

1. Patients who underwent gastrectomy. 2. Patients who underwent transnasal upper gastrointestinal endoscopy.

Design outcomes

Primary

MeasureTime frameDescription
Per patient diagnosis of gastric cancerUp to 6 weeks from study startNumber of Participants

Secondary

MeasureTime frameDescription
Intersection over union (IOU) of gastric lesionsUp to 6 weeks from study startA value between 0 and 1
Diagnosis of advanced gastric cancerUp to 6 weeks from study startNumber of Participants diagnosed with advanced gastric cancer
Diagnosis of early gastric cancerUp to 6 weeks from study startNumber of Participants diagnosed with early gastric cancer
Agreement on image and IOU based diagnosis of gastric cancer between AI and expert endoscopistsUp to 12 weeks from study startNumber of images and IOU value (between 0 and 1)
Number of images analyzed for diagnosis of gastric cancerUp to 6 weeks from study startNumber of upper gastrointestinal endoscopy images

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026